World Aging & Longevity Conference
October 08-10, 2026
Andropause
Andropause refers to gradual age-associated decline in androgen levels, particularly testosterone, in males. Unlike menopause, andropause is progressive and variable across individuals. Declining testosterone affects muscle mass, bone density, fat distribution, energy metabolism, mood, and cognitive function. Andropause is also associated with reduced anabolic signaling and altered cardiovascular and metabolic regulation. Chronic inflammation and metabolic stress can exacerbate hormonal decline. Andropause reflects interaction between endocrine aging and systemic biological aging processes. Understanding andropause provides insight into male-specific aging trajectories and highlights the role of hormonal regulation in maintaining functional health and resilience across the lifespan.
Kenneth R Pelletier
University of California School of Medicine, United States
Thomas J Webster
Brown University, United States
Jason Beckwith
BioTalent, United Kingdom
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Jose Cordeiro Mateo
International Longevity Summit, Spain
Ashot Khachatryan
National Academy of Sciences of the Republic of Armenia, Armenia
Utpol Das
University of Texas Medical Branch at Galveston, United StatesSubmit your abstract Today
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom